Desipramine in the treatment of adolescents with attention deficit disorder.
Twelve adolescents with attention deficit disorder were treated with desipramine in an open trial to assess its efficacy and safety. Eleven patients improved within 1 month, and improvement was sustained for 6-12 months without significant adverse effects in nine patients.
D000293:Adolescent; D000553:Ambulatory Care; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D002986:Clinical Trials as Topic; D003891:Desipramine / Q000009:adverse effects / Q000627:therapeutic use*; D004244:Dizziness / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D012894:Sleep Stages
D003891:Desipramine